旅行者腹泻的治愈检测粪便培养
Test-of-cure stool cultures for traveler's diarrhea.
作者信息
Ericsson C D, DuPont H L, Mathewson J J, Johnson P C, de la Cabada F J, Bitsura J A
机构信息
Program in Infectious Diseases and Clinical Microbiology, University of Texas Medical School, Houston 77030.
出版信息
J Clin Microbiol. 1988 May;26(5):1047-9. doi: 10.1128/jcm.26.5.1047-1049.1988.
Abstract
Whether enteropathogens were eradicated or persisted in test-of-cure stool cultures from 251 patients with traveler's diarrhea, the durations of diarrhea were similar within the antimicrobial agent-treated (32 versus 33 h) and placebo-treated (82 versus 96 h) groups. Routine test-of-cure stool cultures can be useful for evaluating treatment failures and for assessing asymptomatic carriage of enteropathogens after treatment, but they are not mandated in the design of placebo-controlled antimicrobial treatment trials in traveler's diarrhea when the focus of the trial is clinical efficacy.
摘要
在251例旅行者腹泻患者的治愈后粪便培养中，无论肠道病原体是被根除还是持续存在，抗菌药物治疗组（32小时对33小时）和安慰剂治疗组（82小时对96小时）的腹泻持续时间相似。常规的治愈后粪便培养有助于评估治疗失败情况以及治疗后评估肠道病原体的无症状携带情况，但当试验重点是临床疗效时，在旅行者腹泻的安慰剂对照抗菌治疗试验设计中并不强制要求进行此类培养。
相似文献
1
Test-of-cure stool cultures for traveler's diarrhea.旅行者腹泻的治愈检测粪便培养
J Clin Microbiol. 1988 May;26(5):1047-9. doi: 10.1128/jcm.26.5.1047-1049.1988.
2
Rifamycin SV MMX for the treatment of traveler's diarrhea.利福霉素SV MMX用于治疗旅行者腹泻。
Expert Opin Pharmacother. 2017 Aug;18(12):1269-1277. doi: 10.1080/14656566.2017.1353079. Epub 2017 Jul 27.
3
Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin.在使用诺氟沙星成功预防旅行者腹泻期间，未出现耐药性粪便菌群。
Antimicrob Agents Chemother. 1986 Nov;30(5):671-4. doi: 10.1128/AAC.30.5.671.
4
Spectrum of enteropathogens in cases of traveler's diarrhea that were detected using the FilmArray GI panel: New epidemiology in Japan.使用FilmArray GI检测板检测出的旅行者腹泻病例中的肠道病原体谱：日本的新流行病学情况
J Infect Chemother. 2021 Jan;27(1):49-54. doi: 10.1016/j.jiac.2020.08.009. Epub 2020 Aug 22.
5
Evaluation and Management of Traveler's Diarrhea in Children.儿童旅行者腹泻的评估与管理。
Pediatr Clin North Am. 2022 Feb;69(1):99-113. doi: 10.1016/j.pcl.2021.08.004.
6
Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study.氧氟沙星治疗旅行者腹泻五日与三日疗法：一项安慰剂对照研究。
Antimicrob Agents Chemother. 1992 Jan;36(1):87-91. doi: 10.1128/AAC.36.1.87.
7
Traveler's diarrhea: a clinical review.旅行者腹泻：临床综述。
JAMA. 2015 Jan 6;313(1):71-80. doi: 10.1001/jama.2014.17006.
8
[Consensus paper treatment of acute traveler's diarrhea. Practice recommendation for travel advice].[急性旅行者腹泻的共识性治疗文件。旅行建议的实践推荐]
MMW Fortschr Med. 2017 Mar;159(Suppl 4):4-11. doi: 10.1007/s15006-017-9293-2. Epub 2017 Feb 27.
9
Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.利福昔明对比环丙沙星治疗旅行者腹泻：一项随机双盲临床试验。
Clin Infect Dis. 2001 Dec 1;33(11):1807-15. doi: 10.1086/323814. Epub 2001 Oct 23.
10
Nonantimicrobial agents in the prevention and treatment of traveler's diarrhea.用于预防和治疗旅行者腹泻的非抗菌药物。
Clin Infect Dis. 2005 Dec 1;41 Suppl 8:S557-63. doi: 10.1086/432952.
引用本文的文献
1
Rifamycin SV MMX: A Review in the Treatment of Traveller's Diarrhoea.利福昔明 MMX：旅行者腹泻治疗中的一个综述。
Clin Drug Investig. 2019 Jul;39(7):691-697. doi: 10.1007/s40261-019-00808-2.
2
Rifamycin SV-MMX® for treatment of travellers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria.利福昔明 MMX 治疗旅行者腹泻：与环丙沙星同样有效，且不与耐药菌的产生相关。
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay116.
3
Resistant pathogens as causes of traveller's diarrhea globally and impact(s) on treatment failure and recommendations.全球范围内耐药病原体作为旅行者腹泻的病因及其对治疗失败的影响和建议
J Travel Med. 2017 Apr 1;24(suppl_1):S6-S12. doi: 10.1093/jtm/taw090.
4
Rifaximin: a review of its use in the management of traveller's diarrhoea.利福昔明：用于治疗旅行者腹泻的综述
Drugs. 2005;65(12):1697-713. doi: 10.2165/00003495-200565120-00011.
5
Five versus three days of ofloxacin therapy for traveler's diarrhea: a placebo-controlled study.氧氟沙星治疗旅行者腹泻五日与三日疗法：一项安慰剂对照研究。
Antimicrob Agents Chemother. 1992 Jan;36(1):87-91. doi: 10.1128/AAC.36.1.87.
本文引用的文献
1
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni.红霉素对空肠弯曲菌胎儿亚种粪便排泄的影响。
J Infect Dis. 1982 Jan;145(1):128. doi: 10.1093/infdis/145.1.128.
2
Treatment of travelers' diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone.用甲氧苄啶/磺胺甲恶唑和单用甲氧苄啶治疗旅行者腹泻。
N Engl J Med. 1982 Sep 30;307(14):841-4. doi: 10.1056/NEJM198209303071401.
3
Furazolidone versus ampicillin in the treatment of traveler's diarrhea.呋喃唑酮与氨苄西林治疗旅行者腹泻的比较。
Antimicrob Agents Chemother. 1984 Aug;26(2):160-3. doi: 10.1128/AAC.26.2.160.
4
Bicozamycin, a poorly absorbable antibiotic, effectively treats travelers' diarrhea.
Ann Intern Med. 1983 Jan;98(1):20-5. doi: 10.7326/0003-4819-98-1-20.
5
Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis.红霉素治疗空肠弯曲菌肠炎的双盲安慰剂对照试验。
Lancet. 1982 Jan 16;1(8264):131-2. doi: 10.1016/s0140-6736(82)90380-4.
6
Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial.环丙沙星或复方新诺明作为旅行者腹泻的初始治疗：一项安慰剂对照随机试验
Ann Intern Med. 1987 Feb;106(2):216-20. doi: 10.7326/0003-4819-106-2-216.
7
Role of a novel antidiarrheal agent, BW942C, alone or in combination with trimethoprim-sulfamethoxazole in the treatment of traveler's diarrhea.新型止泻药BW942C单独或与甲氧苄啶-磺胺甲恶唑联合用于治疗旅行者腹泻的作用
Antimicrob Agents Chemother. 1986 Jun;29(6):1040-6. doi: 10.1128/AAC.29.6.1040.
8
Early treatment with erythromycin of Campylobacter jejuni-associated dysentery in children.儿童空肠弯曲菌相关性痢疾的红霉素早期治疗
J Pediatr. 1986 Aug;109(2):355-60. doi: 10.1016/s0022-3476(86)80404-8.
9
Single-dose tetracycline therapy for shigellosis in adults.
JAMA. 1978 Feb 27;239(9):853-4.
10
Isolation of enteric pathogens from asymptomatic students from the United States and Latin America.
J Infect Dis. 1977 Jun;135(6):1003-5. doi: 10.1093/infdis/135.6.1003.
Zotero 插件